Log in to save to my catalogue

Clinical actionability of molecular targets in endometrial cancer

Clinical actionability of molecular targets in endometrial cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7446243

Clinical actionability of molecular targets in endometrial cancer

About this item

Full title

Clinical actionability of molecular targets in endometrial cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Cancer, 2019-09, Vol.19 (9), p.510-521

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Endometrial cancer accounts for ~76,000 deaths among women each year worldwide. Disease mortality and the increasing number of new diagnoses make endometrial cancer an important consideration in women’s health, particularly in industrialized countries, where the incidence of this tumour type is highest. Most endometrial cancers are carcinomas, with...

Alternative Titles

Full title

Clinical actionability of molecular targets in endometrial cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7446243

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7446243

Other Identifiers

ISSN

1474-175X

E-ISSN

1474-1768

DOI

10.1038/s41568-019-0177-x

How to access this item